Does Omeprazole Cause Cancer?
Myths and Realities According to Scientific Evidence
TL;DR - Key Points
Omeprazole does NOT directly cause cancer in humans according to current scientific evidence.
The most recent studies and meta-analyses show no established causal relationship between PPIs and gastric cancer.
Long-term use may cause real side effects: B12 deficiency, hypomagnesemia, bone fractures, and gastric rebound.
The key is appropriate use: correct indications, adequate duration, and medical supervision.
The Question That Worries My Patients
Almost every week, a patient comes to my office with the same concern: "Doctor, I've been told that omeprazole causes cancer. Should I stop taking it?" This fear, often fueled by alarming headlines and misinformation on social media, has become one of the most frequent consultations in my practice.
As I always tell my patients: medicine is not about opinions, it's about evidence. And the evidence regarding omeprazole and cancer is much more reassuring than what many people think. Let me explain what current science really tells us.
In my 20 years of clinical practice, I've seen how misinformation can be more harmful than the medications themselves. Patients who abruptly stop their treatment due to unfounded fears often end up with serious complications from untreated gastroesophageal reflux or peptic ulcers.
What Does Current Scientific Evidence Say?
The Most Recent Studies
The most comprehensive and recent meta-analyses, including systematic reviews published in 2023 and 2024, are conclusive: omeprazole has not been shown to directly cause cancer in humans.
The American Gastroenterological Association (AGA) and the American College of Gastroenterology (ACG) agree that the causal relationship between proton pump inhibitors (PPIs) and gastric cancer is not established, and that the absolute risk, if it exists, is very low.
Controlled Clinical Trials
Randomized controlled trials, the gold standard in medical research, have not confirmed a significant increase in gastric cancer risk or premalignant lesions in most studies.
Animal Studies vs. Human Reality
Animal studies show hyperplasia and neuroendocrine tumors at doses much higher than those used in humans, without this being clinically replicated.
Myths vs. Scientific Reality
MYTH: "Omeprazole causes stomach cancer"
This belief comes from misinterpreting observational studies that showed statistical associations, not causation.
REALITY: No direct causal relationship established
The most rigorous studies, free from confounding biases, have not confirmed this relationship. The association observed in some studies may be due to confounding factors such as H. pylori infection or other risk factors.
MYTH: "Any long-term use is dangerous"
This generalization ignores that for many patients, the benefits far outweigh the risks.
REALITY: Risk-benefit must be individualized
As I tell my patients: each case is unique. For someone with severe reflux esophagitis or Barrett's esophagus, the benefits of treatment clearly outweigh the potential risks.
Real Side Effects We Should Monitor
Documented Effects of Long-term Use
While cancer is not a proven risk, there are other effects that are scientifically documented and that I monitor in my patients:
Nutritional Deficiencies
- • Vitamin B12 deficiency: Can cause anemia and neurological problems
- • Hypomagnesemia: Low magnesium levels
- • Iron deficiency: Especially in predisposed patients
Bone Health
- • Increased fracture risk: Especially hip, wrist, and spine
- • Decreased calcium absorption: Important in older adults
Infections
- • Clostridioides difficile: Increased risk of intestinal infection
- • Pneumonia: Slightly higher risk in some patients
Renal Effects
- • Acute interstitial nephritis: Rare but serious
- • Chronic kidney disease: Controversial association
My Clinical Recommendations
Smart Use of Omeprazole
1. Appropriate Indications
Use omeprazole only when there's a clear medical indication: gastroesophageal reflux disease, peptic ulcers, H. pylori eradication, or gastroprotection in high-risk patients.
2. Adequate Duration
Not all patients need lifelong treatment. In my practice, I regularly reassess the need to continue therapy and try to use the lowest effective dose.
3. Regular Monitoring
In patients on long-term treatment, I monitor B12 levels, magnesium, and bone health, especially in older adults.
4. Gradual Discontinuation
Never stop abruptly. Acid rebound is real and can be more bothersome than the original symptoms. I always plan a gradual reduction when appropriate.
When Should You Consult Your Doctor?
Schedule an Appointment If:
- You've been taking omeprazole for more than 8 weeks without medical supervision
- You experience new symptoms while on treatment
- You want to know if you can reduce the dose or stop the medication
- You have concerns about side effects or interactions
- You need a personalized risk-benefit evaluation
Final Conclusion
After reviewing all available scientific evidence, I can confidently tell my patients that omeprazole does not cause cancer. This fear, while understandable, is not supported by current medical evidence.
However, this doesn't mean we should use it carelessly. Like any medication, omeprazole has real risks that we must know and monitor. The key is individualized, evidence-based medicine: using the right medication, in the right patient, at the right dose, and for the right duration.
Remember: fear should never be the reason to abandon an effective treatment, just as comfort should never be the reason to continue an unnecessary one.
Scientific References
- 1. Freedberg DE, Kim LS, Yang YX. The Risks and Benefits of Long-Term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association. Gastroenterology. 2017;152(4):706-715.
- 2. Zheng Z, Lu Z, Song Y. Long-Term Proton Pump Inhibitors Use and Its Association With Premalignant Gastric Lesions: A Systematic Review and Meta-Analysis. Frontiers in Pharmacology. 2023;14:1244400.
- 3. Richman CM, Leiman DA. Can We StoP Worrying About Long-Term PPIs and Gastric Cancer Risk?. Cancer Epidemiology, Biomarkers & Prevention. 2023;32(9):1127-1129.
- 4. Lv F, Wang J, Mao L, et al. Whether Long-Term Use of Proton Pump Inhibitor Increases the Risk of Precancerous Lesions in the Stomach: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicine. 2023;102(38):e35062.
- 5. Katz PO, Dunbar KB, Schnoll-Sussman FH, et al. ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease. The American Journal of Gastroenterology. 2022;117(1):27-56.
- 6. Zhang YJ, Duan DD, Tian QY, Wang CE, Wei SX. A Pharmacovigilance Study of the Association Between Proton Pump Inhibitors and Tumor Adverse Events Based on the FDA Adverse Event Reporting System Database. Frontiers in Pharmacology. 2024;15:1524903.
- 7. Zhang H, Meng X, Gou D, et al. A Meta-Analysis of the Effects of Proton Pump Inhibitors on the Risk of Gastric Cancer. Medicine. 2025;104(28):e43053.
- 8. Waldum HL, Sørdal Ø, Fossmark R. Proton Pump Inhibitors (PPIs) May Cause Gastric Cancer - Clinical Consequences. Scandinavian Journal of Gastroenterology. 2018;53(6):639-642.
- 9. Prilosec. Food and Drug Administration. Updated date: 2024-03-19.
- 10. Maret-Ouda J, Markar SR, Lagergren J. Gastroesophageal Reflux Disease: A Review. JAMA. 2020;324(24):2536-2547.
Dr. Pedro de María Pallarés
Gastroenterologist | Evidence-Based Medicine Specialist
Do you have questions about your digestive health? I'm here to help you with personalized, evidence-based care.
Schedule Your Appointment